What is the optimal venous thromboembolism prophylaxis for gynecological oncology patients with CNS metastases?

ArticleinGynecologic Oncology 123(2):409-10 · July 2011with9 Reads
Impact Factor: 3.77 · DOI: 10.1016/j.ygyno.2011.06.032 · Source: PubMed

    Abstract

    Highlights
    ► CNS metastases of gynecologic cancers will be seen more frequently in the future. ► Chemical thromboprophylaxis carries perioperative risk for neurosurgical procedures. ► Peer-reviewed literature has not addressed the risks and benefits of thromboprophylaxis in gynecologic metastases to the CNS.